Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Neurochem Res Retrieve available abstracts of 76 articles: HTML format

Single Articles

May 2024
1. KUEDO Z, Binlateh T, Benjakul S, Hutamekalin P, et al
   Pretreatment with Liposome-Encapsulated Shrimp Shell Extract Attenuated Neuronal Damage and Death in Abeta(1-42)-Induced Memory Deficits in Rats.
   Neurochem Res. 2024;49:1166-1187.
   PubMed     Abstract available
   
   
   March 2024
2. XIAO X, Rui Y, Jin Y, Chen M, et al
   Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
   Neurochem Res. 2024;49:568-582.
   PubMed     Abstract available
   
   
   February 2024
3. ZHANG LJ, Zhang HZ, Liu YW, Tang M, et al
   Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
   Neurochem Res. 2024 Feb 2. doi: 10.1007/s11064-024-04107.
   PubMed     Abstract available
   
   
   
4. ALLNUTT MA, Matera KM
   Stabilization and Reduced Cytotoxicity of Amyloid Beta Aggregates in the Presence of Catechol Neurotransmitters.
   Neurochem Res. 2024;49:379-387.
   PubMed     Abstract available
   
   
   
5. DHALIWAL N, Dhaliwal J, Chopra K
   7, 8-dihydroxyflavone Ameliorates Cholinergic Dysfunction, Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Vascular Dementia.
   Neurochem Res. 2024 Feb 1. doi: 10.1007/s11064-023-04090.
   PubMed     Abstract available
   
   
   January 2024
6. LIU Y, Meng XK, Shao WZ, Liu YQ, et al
   miR-34a/TAN1/CREB Axis Engages in Alleviating Oligodendrocyte Trophic Factor-Induced Myelin Repair Function and Astrocyte-Dependent Neuroinflammation in the Early Stages of Alzheimer's Disease: The Anti-Neurodegenerative Effect of Treadmill Exercise.
   Neurochem Res. 2024 Jan 30. doi: 10.1007/s11064-024-04108.
   PubMed     Abstract available
   
   
   
7. TAKANO-KAWABE K, Matoba K, Nakamura Y, Moriyama M, et al
   Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia.
   Neurochem Res. 2024;49:199-211.
   PubMed     Abstract available
   
   
   
8. NADERI S, Motamedi F, Pourbadie HG, Rafiei S, et al
   Neuroprotective Effects of Ferrostatin and Necrostatin Against Entorhinal Amyloidopathy-Induced Electrophysiological Alterations Mediated by voltage-gated Ca(2+) Channels in the Dentate Gyrus Granular Cells.
   Neurochem Res. 2024;49:99-116.
   PubMed     Abstract available
   
   
   November 2023
9. ZHAN Q, Kong F, Shao S, Zhang B, et al
   Pathogenesis of Depression in Alzheimer's Disease.
   Neurochem Res. 2023 Nov 28. doi: 10.1007/s11064-023-04061.
   PubMed     Abstract available
   
   
   October 2023
10. SASIDHARAN R, Mohanan R, Kukreti N, Raj P, et al
    MAO-B Inhibitor (2E)-3-(4-Bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one as a Neuroprotective Agent Against Alzheimer's Disease.
    Neurochem Res. 2023 Oct 9. doi: 10.1007/s11064-023-04031.
    PubMed     Abstract available
    
    
    September 2023
11. WU Z, Tang W, Ibrahim FEEM, Chen X, et al
    Abeta Induces Neuroinflammation and Microglial M1 Polarization via cGAS-STING-IFITM3 Signaling Pathway in BV-2 Cells.
    Neurochem Res. 2023;48:2881-2894.
    PubMed     Abstract available
    
    
    
12. ASGHAR H, Ahmed T
    Comparative Study of Time-Dependent Aluminum Exposure and Post-Exposure Recovery Shows Better Improvement in Synaptic Changes and Neuronal Pathology in Rat Brain After Short-Term Exposure.
    Neurochem Res. 2023;48:2731-2753.
    PubMed     Abstract available
    
    
    August 2023
13. PANG LW, Hamzah S, Tan SLJ, Mah SH, et al
    The Effects and Mechanisms of Xanthones in Alzheimer's Disease: A Systematic Review.
    Neurochem Res. 2023 Aug 14. doi: 10.1007/s11064-023-04005.
    PubMed     Abstract available
    
    
    May 2023
14. ZHOU Y, Wang Y, Wang Y, Chen L, et al
    LncRNA NKILA Exacerbates Alzheimer's Disease Progression by Regulating the FOXA1-Mediated Transcription of TNFAIP1.
    Neurochem Res. 2023 May 23. doi: 10.1007/s11064-023-03944.
    PubMed     Abstract available
    
    
    April 2023
15. SIDDIQUI N, Ali J, Parvez S, Najmi AK, et al
    Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Neurochem Res. 2023 Apr 20. doi: 10.1007/s11064-023-03924.
    PubMed     Abstract available
    
    
    
16. LIM D, Tapella L, Dematteis G, Talmon M, et al
    Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.
    Neurochem Res. 2023;48:1077-1090.
    PubMed     Abstract available
    
    
    
17. HUFFELS CFM, Middeldorp J, Hol EM
    Ass Pathology and Neuron-Glia Interactions: A Synaptocentric View.
    Neurochem Res. 2023;48:1026-1046.
    PubMed     Abstract available
    
    
    February 2023
18. ZHANG X, Subbanna S, Williams CRO, Canals-Baker S, et al
    Anti-inflammatory Action of BT75, a Novel RARalpha Agonist, in Cultured Microglia and in an Experimental Mouse Model of Alzheimer's Disease.
    Neurochem Res. 2023 Feb 13. doi: 10.1007/s11064-023-03888.
    PubMed     Abstract available
    
    
    
19. GUO S, Lei Q, Guo H, Yang Q, et al
    Edaravone Attenuates Abeta 1-42-Induced Inflammatory Damage and Ferroptosis in HT22 Cells.
    Neurochem Res. 2023;48:570-578.
    PubMed     Abstract available
    
    
    
20. SHARMA V, Singh TG, Kaur A, Mannan A, et al
    Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders.
    Neurochem Res. 2023;48:317-339.
    PubMed     Abstract available
    
    
    November 2022
21. AL-KURAISHY HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, et al
    A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease.
    Neurochem Res. 2022 Nov 21. doi: 10.1007/s11064-022-03817.
    PubMed     Abstract available
    
    
    
22. LIU M, Lian B, Lan Z, Sun H, et al
    Transcriptomic Profile Identifies Hippocampal Sgk1 as the Key Mediator of Ovarian Estrogenic Regulation on Spatial Learning and Memory and Abeta Accumulation.
    Neurochem Res. 2022;47:3369-3384.
    PubMed     Abstract available
    
    
    October 2022
23. WU Y, Hang Z, Lei T, Du H, et al
    Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones.
    Neurochem Res. 2022 Oct 30. pii: 10.1007/s11064-022-03784.
    PubMed     Abstract available
    
    
    
24. KIRSTEIN M, Cambrils A, Segarra A, Melero A, et al
    Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome.
    Neurochem Res. 2022;47:3076-3092.
    PubMed     Abstract available
    
    
    September 2022
25. SEYEDAGHAMIRI F, Rajabi M, Mohaddes G
    Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.
    Neurochem Res. 2022 Sep 1. pii: 10.1007/s11064-022-03734.
    PubMed     Abstract available
    
    
    
26. HAMAGUCHI T, Ono K, Yamada M
    Transmission of Cerebral beta-Amyloidosis Among Individuals.
    Neurochem Res. 2022;47:2469-2477.
    PubMed     Abstract available
    
    
    
27. NOPPARAT C, Chaopae W, Boontem P, Sopha P, et al
    Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells.
    Neurochem Res. 2022;47:2568-2579.
    PubMed     Abstract available
    
    
    August 2022
28. BHATIA S, Singh M, Singh T, Singh V, et al
    Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer's Disease.
    Neurochem Res. 2022 Aug 20. pii: 10.1007/s11064-022-03722.
    PubMed     Abstract available
    
    
    
29. DE ALMEIDA EJR, Ibrahim HJ, Chitolina Schetinger MR, de Andrade CM, et al
    Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
    Neurochem Res. 2022 Aug 13. pii: 10.1007/s11064-022-03713.
    PubMed     Abstract available
    
    
    
30. LUO JS, Ning JQ, Chen ZY, Li WJ, et al
    The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes.
    Neurochem Res. 2022;47:2158-2172.
    PubMed     Abstract available
    
    
    
31. WANG X, Li B, Yu X, Zhou Y, et al
    The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway.
    Neurochem Res. 2022;47:2405-2415.
    PubMed     Abstract available
    
    
    
32. IBI D, Kondo S, Ohmi A, Kojima Y, et al
    Preventive Effect of Betaine Against Cognitive Impairments in Amyloid beta Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
    Neurochem Res. 2022;47:2333-2344.
    PubMed     Abstract available
    
    
    July 2022
33. KHEZRI MR, Ghasemnejad-Berenji M
    Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Neurochem Res. 2022 Jul 8. pii: 10.1007/s11064-022-03667.
    PubMed     Abstract available
    
    
    June 2022
34. CHINO K, Izuo N, Noike H, Uno K, et al
    Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.
    Neurochem Res. 2022 Jun 27. pii: 10.1007/s11064-022-03649.
    PubMed     Abstract available
    
    
    May 2022
35. EL-GANAINY SO, Soliman OA, Ghazy AA, Allam M, et al
    Intranasal Oxytocin Attenuates Cognitive Impairment, beta-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3beta/Caspase-3.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03624.
    PubMed     Abstract available
    
    
    
36. THENMOZHI AJ, Raja TRW, Janakiraman U, Manivasagam T, et al
    Correction to: Neuroprotective Effect of Hesperidin on Aluminium Chloride Induced Alzheimer's Disease in Wistar Rats.
    Neurochem Res. 2022 May 4. pii: 10.1007/s11064-022-03616.
    PubMed    
    
    
    
37. MANDAL PK, Guha Roy R, Samkaria A, Maroon JC, et al
    In Vivo (13)C Magnetic Resonance Spectroscopy for Assessing Brain Biochemistry in Health and Disease.
    Neurochem Res. 2022;47:1183-1201.
    PubMed     Abstract available
    
    
    
38. ERDOGAN MA, Kirazlar M, Yigitturk G, Erbas O, et al
    Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.
    Neurochem Res. 2022;47:1290-1298.
    PubMed     Abstract available
    
    
    April 2022
39. GHOLIPOUR P, Komaki A, Parsa H, Ramezani M, et al
    Therapeutic Effects of High-Intensity Interval Training Exercise Alone and Its Combination with Ecdysterone Against Amyloid Beta-Induced Rat Model of Alzheimer's Disease: A Behavioral, Biochemical, and Histological Study.
    Neurochem Res. 2022 Apr 29. pii: 10.1007/s11064-022-03603.
    PubMed     Abstract available
    
    
    March 2022
40. SUNKARIA A, Bhardwaj S
    Sleep Disturbance and Alzheimer's Disease: The Glial Connection.
    Neurochem Res. 2022 Mar 18. pii: 10.1007/s11064-022-03578.
    PubMed     Abstract available
    
    
    
41. NGUYEN TT, Hulme J, Vo TK, Van Vo G, et al
    The Potential Crosstalk Between the Brain and Visceral Adipose Tissue in Alzheimer's Development.
    Neurochem Res. 2022 Mar 17. pii: 10.1007/s11064-022-03569.
    PubMed     Abstract available
    
    
    
42. MENG S, Wang B, Li W
    CircAXL Knockdown Alleviates Abeta1-42-Induced Neurotoxicity in Alzheimer's Disease via Repressing PDE4A by Releasing miR-1306-5p.
    Neurochem Res. 2022 Mar 1. pii: 10.1007/s11064-022-03563.
    PubMed     Abstract available
    
    
    February 2022
43. FRONZA MG, Sacramento M, Alves D, Pratico D, et al
    1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Abeta Formation and Tau Phosphorylation in Cellular Models of Alzheimer's Disease.
    Neurochem Res. 2022 Feb 15. pii: 10.1007/s11064-021-03514.
    PubMed     Abstract available
    
    
    
44. SHARMA VK, Singh TG, Prabhakar NK, Mannan A, et al
    Kynurenine Metabolism and Alzheimer's Disease: The Potential Targets and Approaches.
    Neurochem Res. 2022 Feb 8. pii: 10.1007/s11064-022-03546.
    PubMed     Abstract available
    
    
    
45. SHUKLA M, Wongchitrat P, Govitrapong P
    A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.
    Neurochem Res. 2022 Feb 5. pii: 10.1007/s11064-022-03530.
    PubMed     Abstract available
    
    
    January 2022
46. POLIS B, Squillario M, Gurevich V, Srikanth KD, et al
    Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice.
    Neurochem Res. 2022 Jan 31. pii: 10.1007/s11064-021-03519.
    PubMed     Abstract available
    
    
    
47. YU H, Shi J, Lin Y, Zhang Y, et al
    Icariin Ameliorates Alzheimer's Disease Pathology by Alleviating Myelin Injury in 3 x Tg-AD Mice.
    Neurochem Res. 2022 Jan 17. pii: 10.1007/s11064-021-03507.
    PubMed     Abstract available
    
    
    December 2021
48. LIU M, Zhang X, Wang Y
    Curcumin Alleviates Abeta42-Induced Neuronal Metabolic Dysfunction via the Thrb/SIRT3 Axis and Improves Cognition in APPTG Mice.
    Neurochem Res. 2021;46:3166-3178.
    PubMed     Abstract available
    
    
    October 2021
49. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    PubMed     Abstract available
    
    
    
50. VERKERKE M, Hol EM, Middeldorp J
    Physiological and Pathological Ageing of Astrocytes in the Human Brain.
    Neurochem Res. 2021;46:2662-2675.
    PubMed     Abstract available
    
    
    September 2021
51. WAN T, Fu M, Jiang Y, Jiang W, et al
    Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Neurochem Res. 2021 Sep 13. pii: 10.1007/s11064-021-03448.
    PubMed     Abstract available
    
    
    
52. JIANG P, Chen L, Xu J, Liu W, et al
    Neuroprotective Effects of Rhynchophylline Against Abeta1-42-Induced Oxidative Stress, Neurodegeneration, and Memory Impairment Via Nrf2-ARE Activation.
    Neurochem Res. 2021;46:2439-2450.
    PubMed     Abstract available
    
    
    August 2021
53. SHARMA VK, Singh TG, Singh S, Garg N, et al
    Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential.
    Neurochem Res. 2021 Aug 12. pii: 10.1007/s11064-021-03418.
    PubMed     Abstract available
    
    
    
54. KAUR D, Behl T, Sehgal A, Singh S, et al
    Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.
    Neurochem Res. 2021 Aug 6. pii: 10.1007/s11064-021-03415.
    PubMed     Abstract available
    
    
    May 2021
55. ELFOULY A, Awny M, Ibrahim MK, Aboelsaad M, et al
    Effects of Long-Acting Testosterone Undecanoate on Behavioral Parameters and Na + , K(+)-ATPase mRNA Expression in Mice with Alzheimer`s Disease.
    Neurochem Res. 2021 May 25. pii: 10.1007/s11064-021-03357.
    PubMed     Abstract available
    
    
    
56. XIAN-HUI D, Dong-Xue M, Tian-Ci Z, Xiao-Ping H, et al
    The Effect of TCM-Induced HAMP on Key Enzymes in the Hydrolysis of AD Model Cells.
    Neurochem Res. 2021;46:1068-1080.
    PubMed     Abstract available
    
    
    April 2021
57. LEHMANN L, Lo A, Knox KM, Barker-Haliski M, et al
    Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.
    Neurochem Res. 2021 Apr 30. pii: 10.1007/s11064-021-03332.
    PubMed     Abstract available
    
    
    
58. NAZIR S, Anwar F, Saleem U, Ahmad B, et al
    Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.
    Neurochem Res. 2021 Apr 20. pii: 10.1007/s11064-021-03327.
    PubMed     Abstract available
    
    
    
59. UDDIN MS, Sumsuzzman DM, Jeandet P, Behl T, et al
    Deciphering the Interacting Mechanisms of Circadian Disruption and Alzheimer's Disease.
    Neurochem Res. 2021 Apr 19. pii: 10.1007/s11064-021-03325.
    PubMed     Abstract available
    
    
    
60. CAO B, Zeng M, Zhang Q, Zhang B, et al
    Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Abeta25-35-Induced Mice by mTOR Signaling.
    Neurochem Res. 2021;46:921-934.
    PubMed     Abstract available
    
    
    
61. HACIOGLU C, Kar F, Kanbak G
    Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protective Agent on Rat Synaptosomes Treated with Abeta(1-42).
    Neurochem Res. 2021;46:804-818.
    PubMed     Abstract available
    
    
    March 2021
62. SALCEDO C, Wagner A, Andersen JV, Vinten KT, et al
    Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03276.
    PubMed     Abstract available
    
    
    
63. BABAEI P, Eyvani K, Kouhestani S
    Sex-Independent Cognition Improvement in Response to Kaempferol in the Model of Sporadic Alzheimer's Disease.
    Neurochem Res. 2021 Mar 12. pii: 10.1007/s11064-021-03289.
    PubMed     Abstract available
    
    
    February 2021
64. LI J, Xu C, Zhang J, Jin C, et al
    Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses.
    Neurochem Res. 2021 Feb 13. pii: 10.1007/s11064-020-03215.
    PubMed     Abstract available
    
    
    
65. XU Y, Cheng L, Sun J, Li F, et al
    Hypermethylation of Mitochondrial Cytochrome b and Cytochrome c Oxidase II Genes with Decreased Mitochondrial DNA Copy Numbers in the APP/PS1 Transgenic Mouse Model of Alzheimer's Disease.
    Neurochem Res. 2021 Feb 12. pii: 10.1007/s11064-020-03192.
    PubMed     Abstract available
    
    
    
66. LIU X, Wang K, Wei X, Xie T, et al
    Interaction of NF-kappaB and Wnt/beta-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.
    Neurochem Res. 2021 Feb 1. pii: 10.1007/s11064-021-03227.
    PubMed     Abstract available
    
    
    
67. GAO Y, Zhang J, Li S, Zhang Y, et al
    Cattle Encephalon Glycoside and Ignotin Protects Neurons Against Microglia-Induced Neuroinflammation via Elevating BDNF Expression and Inhibiting TLR4/NF-kappaB Pathway.
    Neurochem Res. 2021;46:326-336.
    PubMed     Abstract available
    
    
    
68. CHU F, Li K, Li X, Xu L, et al
    Graphene Oxide Ameliorates the Cognitive Impairment Through Inhibiting PI3K/Akt/mTOR Pathway to Induce Autophagy in AD Mouse Model.
    Neurochem Res. 2021;46:309-325.
    PubMed     Abstract available
    
    
    January 2021
69. ALI M, Saleem U, Anwar F, Imran M, et al
    Screening of Synthetic Isoxazolone Derivative Role in Alzheimer's Disease: Computational and Pharmacological Approach.
    Neurochem Res. 2021 Jan 24. pii: 10.1007/s11064-021-03229.
    PubMed     Abstract available
    
    
    
70. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    PubMed     Abstract available
    
    
    
71. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    PubMed     Abstract available
    
    
    November 2020
72. BALCAR VJ, Zeman T, Janout V, Janoutova J, et al
    Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.
    Neurochem Res. 2020 Nov 18. pii: 10.1007/s11064-020-03176.
    PubMed     Abstract available
    
    
    
73. BAGHERI-MOHAMMADI S
    Microglia in Alzheimer's Disease: The Role of Stem Cell-Microglia Interaction in Brain Homeostasis.
    Neurochem Res. 2020 Nov 10. pii: 10.1007/s11064-020-03162.
    PubMed     Abstract available
    
    
    
74. DING Y, Liu H, Cen M, Tao Y, et al
    Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
    Neurochem Res. 2020 Nov 2. pii: 10.1007/s11064-020-03160.
    PubMed     Abstract available
    
    
    October 2020
75. ORTIZ CJC, Damasio CM, Pruccoli L, Nadur NF, et al
    Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
    Neurochem Res. 2020 Oct 20. pii: 10.1007/s11064-020-03148.
    PubMed     Abstract available
    
    
    April 2020
76. GE Y, Song X, Liu J, Liu C, et al
    The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Abeta25-35 Induced Neuronal Injury Through Regulating the Expression of miR-132-3p in Neuronal Cells.
    Neurochem Res. 2020;45:741-751.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.